68.07BMarket Cap16.15P/E (TTM)
173.51High167.08Low4.62KlotVolume172.88Open172.00Pre Close78.58MTurnover0.51%Turnover RatioLossP/E (Static)401.00MShares215.7152wk High14.10P/B15.35BFloat Cap76.3252wk Low206.40Limit Up90.45MShs Float215.71Historical High137.60Limit Down3.74%Amplitude28.75Historical Low--Dividend TTM169.97Avg Price2.53KlotAsk--Div YieldTTM100Lot Size1.83KlotBid
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet